Prophylactic Antibiotic Use in Hernioplasty (RCT-herniation)
Primary Purpose
Inguinal Hernia
Status
Completed
Phase
Phase 3
Locations
Japan
Study Type
Interventional
Intervention
Antibiotic: cefazolin Sodium
Sponsored by
About this trial
This is an interventional prevention trial for Inguinal Hernia focused on measuring Prophylactic, Antibiotic, Infection, Primary case
Eligibility Criteria
Inclusion Criteria:
- Primary inguinal hernia
- Elective surgery
- Must be older than 20 years of age
- Must not have any serious complication
Exclusion Criteria:
- Incarceration
- Recurrence
- Drug allergy
- Diabetes mellitus
- Malignant diseases
- Serious heart diseases
- Psychological diseases
- Pregnancy
- Have been medicated with corticosteroids
Sites / Locations
- Nihon University School of Medicine, Department of Surgery
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Active Comparator
Arm Label
cont
intervention
Arm Description
Outcomes
Primary Outcome Measures
infectious complication
Secondary Outcome Measures
Recurrence of inguinal hernia
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00636831
Brief Title
Prophylactic Antibiotic Use in Hernioplasty
Acronym
RCT-herniation
Official Title
Prophylactic Antibiotic Use in Inguinal Hernioplasty: A Placebo-controlled, Double-blind Trial
Study Type
Interventional
2. Study Status
Record Verification Date
February 2012
Overall Recruitment Status
Completed
Study Start Date
July 2007 (undefined)
Primary Completion Date
January 2012 (Actual)
Study Completion Date
January 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Nihon University
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to determine whether prophylactic antibiotic use in inguinal hernioplasty are effective in prevention of infectious complication.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inguinal Hernia
Keywords
Prophylactic, Antibiotic, Infection, Primary case
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
400 (Actual)
8. Arms, Groups, and Interventions
Arm Title
cont
Arm Type
Placebo Comparator
Arm Title
intervention
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
Antibiotic: cefazolin Sodium
Intervention Description
1g continuous IV at 30 minutes before starting operation
Primary Outcome Measure Information:
Title
infectious complication
Time Frame
two year
Secondary Outcome Measure Information:
Title
Recurrence of inguinal hernia
Time Frame
two year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Primary inguinal hernia
Elective surgery
Must be older than 20 years of age
Must not have any serious complication
Exclusion Criteria:
Incarceration
Recurrence
Drug allergy
Diabetes mellitus
Malignant diseases
Serious heart diseases
Psychological diseases
Pregnancy
Have been medicated with corticosteroids
Facility Information:
Facility Name
Nihon University School of Medicine, Department of Surgery
City
Tokyo
ZIP/Postal Code
179-0072
Country
Japan
12. IPD Sharing Statement
Learn more about this trial
Prophylactic Antibiotic Use in Hernioplasty
We'll reach out to this number within 24 hrs